X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (319) 319
humans (269) 269
animals (210) 210
neurosciences (206) 206
raclopride - pharmacokinetics (196) 196
adult (177) 177
positron emission tomography (173) 173
raclopride (171) 171
female (166) 166
receptors, dopamine d2 - metabolism (164) 164
pet (148) 148
brain - metabolism (141) 141
brain - diagnostic imaging (136) 136
dopamine (135) 135
dopamine antagonists - pharmacokinetics (135) 135
tomography, emission-computed (131) 131
dopamine - metabolism (121) 121
positron-emission-tomography (114) 114
index medicus (111) 111
c-11 raclopride (108) 108
corpus striatum - metabolism (104) 104
rats (103) 103
corpus striatum - diagnostic imaging (100) 100
psychiatry (93) 93
middle aged (91) 91
positron-emission tomography (84) 84
radiopharmaceuticals - pharmacokinetics (82) 82
radiology, nuclear medicine & medical imaging (79) 79
brain - drug effects (78) 78
pharmacology & pharmacy (77) 77
brain (76) 76
dose-response relationship, drug (76) 76
positron-emission tomography - methods (76) 76
carbon radioisotopes (71) 71
salicylamides - pharmacokinetics (65) 65
schizophrenia (65) 65
binding (64) 64
receptors, dopamine d2 - drug effects (63) 63
corpus striatum - drug effects (60) 60
antipsychotic agents - pharmacokinetics (59) 59
in-vivo (56) 56
receptors (55) 55
receptor (52) 52
brain mapping (49) 49
tissue distribution (48) 48
rats, sprague-dawley (46) 46
aged (45) 45
time factors (44) 44
c-11 raclopride binding (43) 43
kinetics (42) 42
carbon radioisotopes - pharmacokinetics (40) 40
schizophrenia - drug therapy (39) 39
striatum (39) 39
rat-brain (38) 38
raclopride - metabolism (37) 37
c]raclopride (35) 35
clinical neurology (35) 35
radioligand assay (35) 35
dopamine d (34) 34
dopamine receptors (34) 34
human-brain (34) 34
parkinsons-disease (34) 34
binding, competitive - drug effects (33) 33
dopamine antagonists - pharmacology (33) 33
neostriatum - metabolism (33) 33
autoradiography (32) 32
dopamine d2 receptor antagonists (31) 31
microdialysis (31) 31
pharmacokinetics (31) 31
receptors, dopamine - metabolism (31) 31
schizophrenia - metabolism (31) 31
tomography, emission-computed - methods (31) 31
amphetamine - pharmacology (30) 30
cerebellum - metabolism (30) 30
ligands (30) 30
nucleus-accumbens (30) 30
reference values (30) 30
amphetamine (29) 29
endogenous dopamine (29) 29
living human-brain (29) 29
mice (29) 29
schizophrenia - diagnostic imaging (29) 29
brain chemistry - drug effects (28) 28
cerebellum - diagnostic imaging (28) 28
image processing, computer-assisted (28) 28
putamen - metabolism (28) 28
raclopride - pharmacology (28) 28
reproducibility of results (28) 28
computer simulation (27) 27
[c-11]raclopride (26) 26
carbon isotopes - pharmacokinetics (26) 26
cocaine - pharmacokinetics (26) 26
magnetic resonance imaging (26) 26
analysis of variance (25) 25
parkinson disease - diagnostic imaging (25) 25
rat (25) 25
basal ganglia (24) 24
receptor-binding (24) 24
sensitivity and specificity (24) 24
benzamides - pharmacokinetics (23) 23
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmacology, ISSN 0014-2999, 04/2008, Volume 584, Issue 2-3, pp. 318 - 327
In the rat, selective suppression of conditioned avoidance response has been widely reported as a test with high predictive validity for antipsychotic... 
Dopamine D2 receptor occupancy | Antipsychotic | Pharmacokinetic/pharmacodynamic modelling | Rat | Conditioned avoidance response | receptor occupancy | Dopamine D | MOUSE-BRAIN | conditioned avoidance response | rat | SCHIZOPHRENIC-PATIENTS | AVOIDANCE | CLOZAPINE-TREATED PATIENTS | D-2 | pharmacokinetic/pharmacodynamic modelling | ATYPICAL ANTIPSYCHOTICS | IN-VITRO | D2-DOPAMINE RECEPTOR OCCUPANCY | ANIMAL-MODELS | PHARMACOLOGY & PHARMACY | antipsychotic | DOPAMINE-D-2 RECEPTORS | dopamine D-2 receptor occupancy | Benzodiazepines - blood | Rats, Wistar | Antipsychotic Agents - blood | Dopamine Antagonists - pharmacokinetics | Basal Ganglia - metabolism | Risperidone - pharmacokinetics | Raclopride - metabolism | Male | Imidazoles - pharmacokinetics | Receptors, Dopamine D2 - metabolism | Dopamine Antagonists - administration & dosage | Haloperidol - blood | Injections, Subcutaneous | Behavior, Animal - drug effects | Risperidone - blood | Clozapine - blood | Dopamine Antagonists - blood | Clozapine - pharmacokinetics | Binding, Competitive | Reproducibility of Results | Administration, Oral | Conditioning (Psychology) - drug effects | Indoles - blood | Haloperidol - pharmacokinetics | Rats | Benzodiazepines - pharmacokinetics | Antipsychotic Agents - pharmacokinetics | Antipsychotic Agents - administration & dosage | Imidazoles - blood | Animals | Models, Biological | Protein Binding | Indoles - pharmacokinetics | Schizophrenia | Health aspects | Antipsychotic drugs | Dopamine | Metabolites
Journal Article
Journal Article
Journal Article
Journal of Cerebral Blood Flow & Metabolism, ISSN 0271-678X, 1/2012, Volume 32, Issue 1, pp. 127 - 136
Journal Article
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 05/2008, Volume 33, Issue 6, pp. 1441 - 1452
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 04/2005, Volume 25, Issue 15, pp. 3932 - 3939
Journal Article
Journal Article
Journal Article